Pharmaceuticals & Medical Research Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 2,048 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Industry Group Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals Mega (1.1tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (624.3bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (443.6bn) 0 No activity — 0–15%
Pharmaceuticals Mega (326.2bn) 0 No activity — —
Pharmaceuticals Mega (317.8bn) 0 No activity — 0–15%
Pharmaceuticals Mega (297.5bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals Mega (296.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Large (164.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (156.4bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (137.2bn) -1–5 -< $100K -0–15% 0–15%
Biotechnology & Medical Research Large (134.0bn) 0 No activity — 0–15%
Pharmaceuticals Large (115.3bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (105.4bn) 11–20 $100K–$1M 0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (102.5bn) 0 No activity — 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 No activity — —
Biotechnology & Medical Research Large (65.5bn) 0 No activity — 0–15%
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (59.7bn) 1–5 < $100K 0–15% 15–50%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (58.7bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 1–5 $1M–$10M 0–15% —
Biotechnology & Medical Research Large (51.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 No activity — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (41.0bn) 1–5 $100K–$1M 0–15% 0–15%
Biotechnology & Medical Research Large (40.1bn) 0 No activity — 0–15%
Pharmaceuticals Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (38.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (37.7bn) 0 No activity — 0–15%
Pharmaceuticals Large (33.3bn) 0 No activity — 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (32.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (32.0bn) 0 No activity — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (31.9bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (29.8bn) 0 No activity — 0–15%
Pharmaceuticals Large (26.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (26.1bn) -6–10 -$100M+ -0–15% 15–50%
US Insmed Inc (INSM)
Biotechnology & Medical Research Large (24.5bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
US Incyte Corp (INCY)
Biotechnology & Medical Research Large (22.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (22.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (19.9bn) -11–20 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (19.1bn) 0 -$1M–$10M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (18.3bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (18.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (17.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (17.4bn) 0 No activity — 50%+
Pharmaceuticals Large (17.3bn) -6–10 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (16.5bn) 0 No activity — —
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 No activity — 15–50%
Biotechnology & Medical Research Large (15.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals Large (15.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (15.3bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (15.0bn) 0 No activity — 50%+
Biotechnology & Medical Research Large (14.0bn) 0 No activity — 0–15%
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (14.0bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (13.5bn) 0 No activity — 50%+
Biotechnology & Medical Research Large (13.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (12.9bn) 0 No activity — 50%+
Pharmaceuticals Large (12.7bn) 0 No activity — 15–50%
Biotechnology & Medical Research Large (12.6bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (12.6bn) 0 No activity — 15–50%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Large (12.3bn) 0 No activity — 0–15%
Pharmaceuticals Large (12.1bn) 0 No activity — 50%+
Biotechnology & Medical Research Large (12.1bn) 0 No activity — 0–15%
Pharmaceuticals Large (12.0bn) 1–5 $100K–$1M 0–15% 0–15%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (11.8bn) 1–5 $100M+ 0–15% 50%+
Biotechnology & Medical Research Large (11.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (11.5bn) -6–10 -$10M–$100M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 No activity — 0–15%
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (11.2bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (11.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) -6–10 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 No activity — 0–15%
Pharmaceuticals Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (10.1bn) 0 No activity — 0–15%
Pharmaceuticals Mid (9.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Nuvalent Inc (NUVL)
Biotechnology & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Biotechnology & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.9bn) 0 No activity — 0–15%
IE ICON PLC (ICLR)
Biotechnology & Medical Research Mid (8.9bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Biotechnology & Medical Research Mid (8.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (8.8bn) 0 No activity — 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.6bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 No activity — 0–15%
Pharmaceuticals Mid (8.5bn) 0 $100K–$1M 0–15% 0–15%
Biotechnology & Medical Research Mid (8.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Biotechnology & Medical Research Mid (8.2bn) -6–10 -$10M–$100M -0–15% 50%+
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (8.2bn) 0 No activity — 50%+
Biotechnology & Medical Research Mid (8.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%